4-phenylbutyric acid has been researched along with cholecalciferol in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Waxman, S | 1 |
| Agerberth, B; Akhtar, E; Gudmundsson, GH; Kamal, SM; Mily, A; Rahim, Z; Raqib, R; Rekha, RS; Sarker, P | 1 |
| Agerberth, B; Kenne, E; Koppelaar, E; Lindbom, L; van der Does, AM | 1 |
| Agerberth, B; Gudmundsson, GH; Huehnken, C; Kulkarni, NN; Yi, Z | 1 |
| Agerberth, B; Arifuzzaman, AS; Bergman, P; Brighenti, S; Gudmundsson, GH; Haq, MA; Kamal, SM; Khan, L; Mily, A; Rahim, Z; Raqib, R; Rekha, RS; Zaman, K | 1 |
| Espinoza, JC; Estévez, RA; Guðmundsson, GH; Jónsson, ZO; Kuznar, J; Maier, VH; Mostazo, MGC; Rodriguez, E | 1 |
1 review(s) available for 4-phenylbutyric acid and cholecalciferol
| Article | Year |
|---|---|
Differentiation therapy in acute myelogenous leukemia (non-APL).
Topics: Acute Disease; Adult; Aged; Animals; Antineoplastic Agents; Apoptosis; Butyrates; Cell Differentiation; Cholecalciferol; Chromatin; Drug Design; Drug Synergism; Gene Expression Regulation, Leukemic; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid; Ligands; Mice; Middle Aged; Oncogene Proteins, Fusion; Phenylbutyrates; Transcription, Genetic; Translocation, Genetic; Tretinoin | 2000 |
2 trial(s) available for 4-phenylbutyric acid and cholecalciferol
| Article | Year |
|---|---|
Oral intake of phenylbutyrate with or without vitamin D3 upregulates the cathelicidin LL-37 in human macrophages: a dose finding study for treatment of tuberculosis.
Topics: Administration, Oral; Adolescent; Adult; Antimicrobial Cationic Peptides; Antineoplastic Agents; Calcium; Cathelicidins; Cells, Cultured; Cholecalciferol; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Immunity, Innate; Macrophages; Male; Middle Aged; Mycobacterium tuberculosis; Phenylbutyrates; RNA, Messenger; Tuberculosis; Up-Regulation; Vitamins; Young Adult | 2013 |
Significant Effects of Oral Phenylbutyrate and Vitamin D3 Adjunctive Therapy in Pulmonary Tuberculosis: A Randomized Controlled Trial.
Topics: Administration, Oral; Adult; Antimicrobial Cationic Peptides; Antitubercular Agents; C-Reactive Protein; Calcifediol; Calcium; Cathelicidins; Cholecalciferol; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Leukocytes, Mononuclear; Logistic Models; Macrophages; Phenylbutyrates; Placebo Effect; RNA, Messenger; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2015 |
3 other study(ies) available for 4-phenylbutyric acid and cholecalciferol
| Article | Year |
|---|---|
Vitamin D₃ and phenylbutyrate promote development of a human dendritic cell subset displaying enhanced antimicrobial properties.
Topics: Animals; Antimicrobial Cationic Peptides; Cathelicidins; Cell Differentiation; Cells, Cultured; Cholecalciferol; Cytokines; Dendritic Cells; Humans; Mice; Mice, Inbred C57BL; Monocytes; Phenylbutyrates; Reactive Oxygen Species | 2014 |
Phenylbutyrate induces cathelicidin expression via the vitamin D receptor: Linkage to inflammatory and growth factor cytokines pathways.
Topics: Antimicrobial Cationic Peptides; beta-Defensins; Cathelicidins; Cell Line; Cholecalciferol; Cytokines; Flagellin; Gene Silencing; Humans; Inflammation; Intercellular Signaling Peptides and Proteins; Ligands; Microbial Sensitivity Tests; Phenylbutyrates; Pseudomonas aeruginosa; Receptors, Calcitriol; RNA, Messenger; Signal Transduction; Toll-Like Receptor 5; Up-Regulation; Vitamin D3 24-Hydroxylase | 2015 |
Inducers of salmon innate immunity: An in vitro and in vivo approach.
Topics: Aeromonas salmonicida; Animals; Birnaviridae Infections; Cell Line; Cholecalciferol; Fish Diseases; Fish Proteins; Furunculosis; Gene Expression; Gram-Negative Bacterial Infections; Immunity, Innate; Infectious pancreatic necrosis virus; Lipids; Phenylbutyrates; Salmo salar; Valerates | 2018 |